Last updated:2015.10.2.

Data submission of human subjects research

 

Before your submission

For all data from human subjects researches submitted to DDBJ, it is submitter's responsibility to ensure that the privacy of participant (human subject) is protected in accordance with all applicable laws, regulations and policies of submitter's institute.
In principle, make sure to remove any direct personal identifiers of human subjects from your submissions.

When you use samples derived from human subjects except commercial sources, make sure the followings.

  • The research plan with experimental methods and materials for the data from human subjects research was approved by the review board of submitter's institute.
  • The research plan and the documents of informed consents contain clear agreements to submit the data from human subjects research to our database in order to share them among researchers.

 

Controlled access and database

Before data submission of whole genome scale data from human subjects research, please consider whether controlled access for the data is required or not (i.e. unrestricted access) on the basis of informed consents with human subjects.
For controlled access, submit your data to Japanese Genotype-phenotype Archive (JGA)
For unrestricted access, submit your data through DDBJ Sequence Read Archive (DRA) or Mass Submission System (MSS).

 

Review before your submission

Before submitting whole genome scale data from human subjects research, the research plan and the documents of informed consents should be assessed at National Bioscience Database Center (NBDC) as needed.

Required to review
Whole genome sequence of a specific person, patient
Not required to review
Commercial source of human cell lines or tissues except HeLa
Metagenomic analyses for non-human subjects, human microbiome

 

References

ページの先頭へ戻る